Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

1.

Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.

Chaturvedi RK, Beal MF.

Mol Cell Neurosci. 2013 Jul;55:101-14. doi: 10.1016/j.mcn.2012.11.011. Epub 2012 Dec 5. Review.

PMID:
23220289
[PubMed - indexed for MEDLINE]
2.

Mitochondrial diseases of the brain.

Chaturvedi RK, Flint Beal M.

Free Radic Biol Med. 2013 Oct;63:1-29. doi: 10.1016/j.freeradbiomed.2013.03.018. Epub 2013 Apr 6. Review.

PMID:
23567191
[PubMed - indexed for MEDLINE]
3.

Mitochondrial approaches for neuroprotection.

Chaturvedi RK, Beal MF.

Ann N Y Acad Sci. 2008 Dec;1147:395-412. doi: 10.1196/annals.1427.027. Review.

PMID:
19076459
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Mitochondria: a therapeutic target in neurodegeneration.

Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA.

Biochim Biophys Acta. 2010 Jan;1802(1):212-20. doi: 10.1016/j.bbadis.2009.10.007. Epub 2009 Oct 21. Review.

PMID:
19853657
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.

Tsunemi T, La Spada AR.

Prog Neurobiol. 2012 May;97(2):142-51. doi: 10.1016/j.pneurobio.2011.10.004. Epub 2011 Nov 9. Review.

PMID:
22100502
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease.

Beal MF.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S189-94. doi: 10.1016/S1353-8020(09)70812-0.

PMID:
20082988
[PubMed - indexed for MEDLINE]
7.

PGC-1α, mitochondrial dysfunction, and Huntington's disease.

Johri A, Chandra A, Beal MF.

Free Radic Biol Med. 2013 Sep;62:37-46. doi: 10.1016/j.freeradbiomed.2013.04.016. Epub 2013 Apr 19. Review.

PMID:
23602910
[PubMed - indexed for MEDLINE]
8.

Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.

Schapira AH.

Biochim Biophys Acta. 1999 Feb 9;1410(2):159-70. Review.

PMID:
10076024
[PubMed - indexed for MEDLINE]
Free Article
9.

Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.

Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ.

Hum Mol Genet. 2010 Oct 15;19(20):3919-35. doi: 10.1093/hmg/ddq306. Epub 2010 Jul 21.

PMID:
20660112
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Melatonin and mitochondrial dysfunction in the central nervous system.

Cardinali DP, Pagano ES, Scacchi Bernasconi PA, Reynoso R, Scacchi P.

Horm Behav. 2013 Feb;63(2):322-30. doi: 10.1016/j.yhbeh.2012.02.020. Epub 2012 Feb 25. Review.

PMID:
22391273
[PubMed - indexed for MEDLINE]
11.

Mitophagy and Parkinson's disease: be eaten to stay healthy.

de Vries RL, Przedborski S.

Mol Cell Neurosci. 2013 Jul;55:37-43. doi: 10.1016/j.mcn.2012.07.008. Epub 2012 Aug 2. Review.

PMID:
22926193
[PubMed - indexed for MEDLINE]
12.

Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.

Oliveira JM.

J Neurochem. 2010 Jul;114(1):1-12. doi: 10.1111/j.1471-4159.2010.06741.x. Epub 2010 Apr 9. Review.

PMID:
20403078
[PubMed - indexed for MEDLINE]
13.

Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.

Beal MF.

J Bioenerg Biomembr. 2004 Aug;36(4):381-6. Review.

PMID:
15377876
[PubMed - indexed for MEDLINE]
14.

Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.

Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Beal MF.

J Neurochem. 2009 Jun;109(5):1427-39. doi: 10.1111/j.1471-4159.2009.06074.x. Epub 2009 Mar 28.

PMID:
19476553
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease.

Johri A, Calingasan NY, Hennessey TM, Sharma A, Yang L, Wille E, Chandra A, Beal MF.

Hum Mol Genet. 2012 Mar 1;21(5):1124-37. doi: 10.1093/hmg/ddr541. Epub 2011 Nov 17.

PMID:
22095692
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Mitochondria and neurodegeneration.

Petrozzi L, Ricci G, Giglioli NJ, Siciliano G, Mancuso M.

Biosci Rep. 2007 Jun;27(1-3):87-104. Review.

PMID:
17486441
[PubMed - indexed for MEDLINE]
Free Article
17.

The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Van Laar VS, Berman SB.

Neurobiol Dis. 2013 Mar;51:43-55. doi: 10.1016/j.nbd.2012.05.015. Epub 2012 Jun 2. Review.

PMID:
22668779
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.

Guo X, Disatnik MH, Monbureau M, Shamloo M, Mochly-Rosen D, Qi X.

J Clin Invest. 2013 Dec 2;123(12):5371-88. doi: 10.1172/JCI70911. Epub 2013 Nov 15.

PMID:
24231356
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Impaired mitochondrial trafficking in Huntington's disease.

Li XJ, Orr AL, Li S.

Biochim Biophys Acta. 2010 Jan;1802(1):62-5. doi: 10.1016/j.bbadis.2009.06.008. Epub 2009 Jul 8. Review.

PMID:
19591925
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Mitochondrial dysfunction in Parkinson's disease.

Winklhofer KF, Haass C.

Biochim Biophys Acta. 2010 Jan;1802(1):29-44. doi: 10.1016/j.bbadis.2009.08.013. Epub 2009 Sep 3. Review.

PMID:
19733240
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk